Lymph node metastases in pediatric medullary thyroid carcinoma.
Adolescent
Adult
Aged
Aged, 80 and over
Carcinoma, Neuroendocrine
/ diagnosis
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Incidence
Infant
Infant, Newborn
Lymph Nodes
/ pathology
Lymphatic Metastasis
Male
Middle Aged
Neck Dissection
/ methods
Retrospective Studies
Thyroid Neoplasms
/ diagnosis
Thyroidectomy
/ methods
United States
/ epidemiology
Young Adult
Journal
Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
19
11
2020
revised:
14
02
2021
accepted:
01
03
2021
pubmed:
12
4
2021
medline:
26
11
2021
entrez:
11
4
2021
Statut:
ppublish
Résumé
Unlike medullary thyroid carcinoma in adults, the vast majority of pediatric medullary thyroid carcinoma is hereditary. Pediatric medullary thyroid carcinoma is known to have different genetic alterations driving tumorigenesis, but it is not known if pediatric medullary thyroid carcinoma has different clinicopathologic features. This study aims to identify which pediatric medullary thyroid carcinoma patients might warrant elective neck dissection. We selected all patients ages 0 to 19 diagnosed with clinically evident medullary thyroid carcinoma in the National Cancer Database between 2004 to 2016. Clinicopathologic factors, treatments, and outcomes were analyzed and compared between this cohort and adults (ages ≥20) with medullary thyroid carcinoma. One hundred twenty-five pediatric medullary thyroid carcinoma (median age: 13) and 5,086 adult medullary thyroid carcinoma (median age: 57) patients were identified. Pediatric patients had smaller tumors (median diameter: 1.2 cm vs 2.0 cm; P < .001), lower rates of nodal metastases (n = 31, 36.9% vs 1,689, 50.4%; P = .02) but double the incidence of multifocal tumors (n = 70, 59.3%, vs 1,412, 29.9%; P < .001) compared with adults. Multifocal tumors conferred a significantly increased risk of nodal metastases in adult medullary thyroid carcinoma (64.4% vs 43.2%; P < .001) but not pediatric medullary thyroid carcinoma (37.7% vs 35.7%; P = .85). Nodal metastases were more frequent among older children (0-5 years: 0.0%, 6-12: 40.7%, 13-19: 41.7%; P = .04). However, rates of occult nodal metastases were similar between older children (6-19 years: n = 12, 21.4%) and adults (557, 25.8% P = .56). Pediatric medullary thyroid carcinoma has lower rates of lymph node metastases compared with adults. The risk of nodal disease was low among the youngest children, but older children ages 6 to 19 were at considerable risk for occult metastases. These findings could guide clinicians in selecting pediatric patients considered for elective lymph node dissection.
Sections du résumé
BACKGROUND
Unlike medullary thyroid carcinoma in adults, the vast majority of pediatric medullary thyroid carcinoma is hereditary. Pediatric medullary thyroid carcinoma is known to have different genetic alterations driving tumorigenesis, but it is not known if pediatric medullary thyroid carcinoma has different clinicopathologic features. This study aims to identify which pediatric medullary thyroid carcinoma patients might warrant elective neck dissection.
METHODS
We selected all patients ages 0 to 19 diagnosed with clinically evident medullary thyroid carcinoma in the National Cancer Database between 2004 to 2016. Clinicopathologic factors, treatments, and outcomes were analyzed and compared between this cohort and adults (ages ≥20) with medullary thyroid carcinoma.
RESULTS
One hundred twenty-five pediatric medullary thyroid carcinoma (median age: 13) and 5,086 adult medullary thyroid carcinoma (median age: 57) patients were identified. Pediatric patients had smaller tumors (median diameter: 1.2 cm vs 2.0 cm; P < .001), lower rates of nodal metastases (n = 31, 36.9% vs 1,689, 50.4%; P = .02) but double the incidence of multifocal tumors (n = 70, 59.3%, vs 1,412, 29.9%; P < .001) compared with adults. Multifocal tumors conferred a significantly increased risk of nodal metastases in adult medullary thyroid carcinoma (64.4% vs 43.2%; P < .001) but not pediatric medullary thyroid carcinoma (37.7% vs 35.7%; P = .85). Nodal metastases were more frequent among older children (0-5 years: 0.0%, 6-12: 40.7%, 13-19: 41.7%; P = .04). However, rates of occult nodal metastases were similar between older children (6-19 years: n = 12, 21.4%) and adults (557, 25.8% P = .56).
CONCLUSION
Pediatric medullary thyroid carcinoma has lower rates of lymph node metastases compared with adults. The risk of nodal disease was low among the youngest children, but older children ages 6 to 19 were at considerable risk for occult metastases. These findings could guide clinicians in selecting pediatric patients considered for elective lymph node dissection.
Identifiants
pubmed: 33838880
pii: S0039-6060(21)00193-8
doi: 10.1016/j.surg.2021.03.001
pmc: PMC9439710
mid: NIHMS1827352
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
736-742Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
J Pediatr Surg. 2018 Feb;53(2):283-285
pubmed: 29336779
J Pediatr Oncol. 2015;3(2):29-37
pubmed: 27014708
N Engl J Med. 1978 Nov 2;299(18):980-5
pubmed: 692625
J Int Med Res. 2018 May;46(5):1982-1989
pubmed: 29569965
Ann Surg Oncol. 2013 Jan;20(1):53-9
pubmed: 22890595
Acta Oncol. 2016;55(3):357-64
pubmed: 26339947
Nat Rev Endocrinol. 2011 Aug 23;7(10):596-607
pubmed: 21862994
Otolaryngol Head Neck Surg. 2019 Feb;160(2):284-294
pubmed: 30129822
Ann Surg Oncol. 2019 Jun;26(6):1604-1612
pubmed: 30737668
Int J Surg. 2017 May;41 Suppl 1:S2-S6
pubmed: 28506408
J Clin Endocrinol Metab. 2008 Aug;93(8):3058-65
pubmed: 18522977
J Pediatr Surg. 2010 Oct;45(10):1947-54
pubmed: 20920711
J Clin Endocrinol Metab. 2010 Jun;95(6):2655-63
pubmed: 20339026
J Pediatr Surg. 2017 Jan;52(1):120-123
pubmed: 27836371
N Engl J Med. 2003 Oct 16;349(16):1517-25
pubmed: 14561794
Int J Pediatr Otorhinolaryngol. 2016 Oct;89:121-6
pubmed: 27619041
Cancer. 2012 Feb 1;118(3):620-7
pubmed: 21717441
J Clin Oncol. 2009 Sep 1;27(25):4177-81
pubmed: 19636004
Eur J Pediatr Surg. 2016 Dec;26(6):524-532
pubmed: 26683804
World J Surg. 2018 Aug;42(8):2444-2453
pubmed: 29383423
J Clin Endocrinol Metab. 2011 Mar;96(3):E509-18
pubmed: 21190982
Cancer Res. 1996 May 1;56(9):2167-70
pubmed: 8616867
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
Thyroid. 2012 May;22(5):476-81
pubmed: 22404432
Lancet Diabetes Endocrinol. 2019 Mar;7(3):213-220
pubmed: 30660595
J Surg Res. 2009 Sep;156(1):167-72
pubmed: 19631341
Mol Cell Endocrinol. 2008 Mar 12;284(1-2):21-7
pubmed: 18282654